Serum paraoxonase 1 (PON1) activity and the oxidation of lipoproteins were investigated in 35 women with preeclampsia and in 35 healthy control women with normal pregnancies. Blood pressure, body mass index (BMI), serum levels of total cholesterol, triglycerides, high-density lipoprotein (HDL), lowdensity lipoprotein (LDL), apolipoprotein A1 (ApoA1), apolipoprotein B (ApoB) and lipoprotein (a) (Lp[a]), and PON1 activity were assessed. There were no significant between-group differences in subject age, gestational age at diagnosis of preeclampsia, BMI, serum total cholesterol, triglycerides, LDL and ApoB levels. Mean systolic and diastolic blood pressures and serum Lp(a) were significantly higher in subjects with pre-eclampsia than in controls. Mean serum HDL, ApoA1 and PON1 activity were significantly lower in subjects with pre-eclampsia compared with controls. In conclusion, lipids and oxidized lipoproteins may play important roles in the pathogenesis of preeclampsia.
Introduction
Pre-eclampsia -a leading cause of maternal and perinatal mortality and morbidity -is a systemic disease characterized by hypertension, proteinuria and oedema. Endothelial cellular activation and dysfunction play a central role in the pathogenesis of pre-eclampsia. 1, 2 The cause of this endothelial dysfunction is not clearly understood, but may involve lipids and their peroxidation products. 1 Previous studies have shown that pregnancy in general, and pre-eclampsia in particular, are associated with marked hyperlipidaemia. 1 In addition, lipid peroxidation products are elevated in pre-eclampsia. 1,3 - 12 The characteristic preeclamptic uteroplacental lesion is similar to atherosclerotic lesions; both display vesselwall necrosis and accumulation of lipidladen foam cells, a hallmark of oxidized lowdensity lipoproteins (LDL). 1,3 -7 The production of oxidative agents may be induced by poorly perfused placental tissue. 12 Oxidized apolipoprotein B (ApoB)containing lipoproteins are present in dyslipidaemic pre-eclamptic patients, B Demir, S Demir, Y Atamer et al. Serum lipids, lipoproteins and paraoxonase in pre-eclampsia suggesting that these lipoproteins play a role in the pathogenesis of pre-eclampsia. 1 Paraoxonase 1 (PON1), an enzyme associated with high-density lipoprotein (HDL), has been shown to inhibit LDL and HDL oxidation. 13, 14 PON1 activity is decreased in diseases associated with endothelial activation and dysfunction including diabetes, hypercholesterolaemia and cardiovascular disease. 15, 16 The aim of the present study was to investigate changes in lipid parameters, serum PON1 activity and oxidation of lipoproteins in preeclampsia.
Subjects and methods

STUDY PARTICIPANTS
All subjects with pre-eclampsia and healthy controls were recruited from the Department of Obstetrics and Gynaecology, Ergani State Hospital, Diyarbakir, Turkey, between September 2010 and December 2010. The study recruited pregnant women with no history of hypertension who developed preeclampsia during their current pregnancy. All pregnant women with elevated blood pressure were enrolled into the study and monitored regularly at monthly intervals for signs or symptoms of pre-eclampsia including oedema, proteinuria and hypertension. Healthy control subjects with uncomplicated pregnancies were recruited during routine third-trimester outpatient visits. None of the study participants smoked, used caffeine or drank alcohol. None of the study participants had a history of an endocrine disease, hypertension, hyperlipidaemia or antihypertensive drug use. Women with a history of thyroiditis, hyperthyroidism or previously diagnosed hypertension were excluded.
The study was approved by the Ethical Review Committee of Dicle University, Diyarbakir, Turkey, and written informed consent was obtained from all participants.
DATA COLLECTION
The blood pressure of all participants was measured while lying supine in an airconditioned room at 22°C. Body mass index (BMI) was calculated in kg/m 2 . Blood samples were collected from participants between 08.00 h and 10.00 h after an overnight fast of ≥ 12 h; samples were collected in a dry tube and studied immediately. Blood was taken from preeclamptic subjects immediately after diagnosis and before medication was administered, and from controls during routine visits. Serum levels of total cholesterol, triglycerides, HDL and LDL were determined using an Aeroset autoanalyser (Abbott Laboratories, Abbott Park, IL, USA). Levels of serum apolipoprotein A-1 (ApoA1) and ApoB were evaluated via nephelometric assays (Dade Behring, Newark, DE, USA) according to the manufacturer's instructions. Serum lipoprotein (a) (Lp[a]) levels were measured by nephelometric agglutination assay (N latex Lp(a) reagent; Dade Behring) according to the manufacturer's instructions. Serum PON1 activity was measured as described by Furlong et al., 17 and expressed as U/l.
STATISTICAL ANALYSES
Statistical analyses were performed using the SPSS ® statistical package, version 10.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . Data are presented as mean ± SD. The independent t-test was used to analyse differences between groups. Pearson's correlation coefficient was determined by linear regression analysis. A P-value < 0.05 was considered to be statistically significant.
Results
The study recruited 35 women with pre-B Demir, S Demir, Y Atamer et al. Serum lipids, lipoproteins and paraoxonase in pre-eclampsia eclampsia and 35 healthy control subjects. Three women with a history of thyroiditis or hyperthyroidism and one with a history of previously diagnosed hypertension were excluded; none of the participants had a history of endocrine disease, hypertension, hyperlipidaemia or antihypertensive drug use. There were no statistically significant between-group differences in subject age or gestational age at diagnosis of preeclampsia.
Mean systolic and diastolic blood pressures were significantly higher in preeclamptic subjects than healthy controls (P < 0.0001). There were no statistically significant between-group differences in BMI or serum total cholesterol, triglyceride, LDL and ApoB levels. Serum HDL, ApoA1 and PON1 activity was significantly lower in preeclamptic subjects compared with controls (all P < 0.0001). Serum Lp(a) levels were significantly elevated in pre-eclamptic subjects compared with controls (P < 0.0001) ( Table 1) .
Activity of PON1 was negatively correlated with systolic and diastolic blood pressure, serum HDL, Lp(a), ApoA1 and ApoB (P < 0.0001).
Discussion
It is thought that lipids and oxidized lipoproteins play important roles in the pathogenesis of pre-eclampsia. Previous studies have reported increased levels of LDL and HDL oxidation, and the presence of antibodies directed against oxidized LDL in pre-eclamptic patients. 18 -21 A previous study has demonstrated raised levels of ApoBcontaining lipoproteins and serum triglycerides in pre-eclampsia, possibly increasing the oxidation of ApoB-containing lipoproteins such as small dense LDL and Lp(a), due to increased oxidative stress caused by hypertension. 1 Previous studies have found that total cholesterol and LDL levels are not elevated in pre-eclamptic 1, 22 This is in agreement with the present finding that serum triglycerides, total cholesterol, LDL and ApoB levels were similar in pre-eclamptic subjects and healthy controls. Serum levels of HDL were significantly lower, and Lp(a) levels were significantly higher, in the pre-eclamptic women compared with the controls, a finding that is consistent with an earlier study showing unchanged or decreased HDL in pre-eclampsia. 1 Data on apolipoprotein levels in pre-eclampsia are limited and controversial. Several studies have found no significant differences in ApoA1 levels; 9, 11, 23 others reported decreased ApoA1 levels in pre-eclampsia, 24 a finding that is consistent with the present study. Serum ApoB levels have been shown to be increased 11, 25 or unchanged 9, 23 in pre-eclampsia. The present study demonstrated no difference in ApoB levels between pre-eclamptic subjects and healthy controls. Several currently undefined factors may affect lipoprotein levels in pregnancy and pre-eclampsia, and it is clear that large-scale studies are needed to clarify the effects of lipids, lipoproteins and their oxidized products on pre-eclampsia.
Paraoxonase 1 is an HDL-associated antioxidant enzyme whose activity is decreased in conditions associated with oxidative stress. 1 The present study found a negative correlation between PON1 activity and blood pressure and serum Lp(a). A previous study found that serum PON1 activity was decreased in women with severe pre-eclampsia, and the authors suggested that decreased PON1 activity may be related to liver damage. 22, 24 PON1 activity was significantly lower in pre-eclamptic subjects compared with controls in the present study. Serum
ApoB-containing lipoproteins increase in pregnancies in general. The present study group had similar serum ApoB-containing lipoprotein levels to those found in controls, and it is possible that decreased PON1 activity may help to maintain levels of ApoB-containing lipoproteins within the normal range because of its decreased antioxidant activity.
In conclusion, lipids and oxidated lipoproteins play a role in the pathogenesis of pre-eclampsia. Large-scale studies are needed to elucidate the pathogenic mechanism of pre-eclampsia.
